The Use of Combination Therapies in the Frontline Setting for CLL

Zahra Mahmoudjafari, PharmD, BCOP, DPLA, opens a discussion surrounding chronic lymphocytic leukemia (CLL).

Dr Mahmoudjafari highlights the changing treatment landscape for patients with CLL.

CAPTIVATE FD and GLOW studies results and takeaways are discussed by Dr Mahmoudjafari.

Dr Mahmoudjafari explores the role of BTK inhibitors in the treatment of CLL.

In her closing thoughts, Dr Mahmoudjafari provides an overview of cardiovascular implications associated with CLL as well as the impact of pharmacists in CLL treatment management.